Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas

O Mete, SL Asa, AJ Gill, N Kimura, RR de Krijger… - Endocrine …, 2022 - Springer
This review summarizes the classification of tumors of the adrenal medulla and extra-
adrenal paraganglia as outlined in the 5th series of the WHO Classification of Endocrine and …

Personalized management of pheochromocytoma and paraganglioma

S Nölting, N Bechmann, D Taieb… - Endocrine …, 2022 - academic.oup.com
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

[HTML][HTML] An overview: the diversified role of mitochondria in cancer metabolism

Y Sun, Y Guo, X Shi, X Chen, W Feng… - … journal of biological …, 2023 - ncbi.nlm.nih.gov
Mitochondria are intracellular organelles involved in energy production, cell metabolism and
cell signaling. They are essential not only in the process of ATP synthesis, lipid metabolism …

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

JWM Lenders, QY Duh, G Eisenhofer… - The Journal of …, 2014 - academic.oup.com
Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …

The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia

JR Srigley, B Delahunt, JN Eble, L Egevad… - The American journal …, 2013 - journals.lww.com
The classification working group of the International Society of Urological Pathology
consensus conference on renal neoplasia was in charge of making recommendations …

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

J Favier, L Amar, AP Gimenez-Roqueplo - Nature Reviews …, 2015 - nature.com
Paragangliomas and phaeochromocytomas are neuroendocrine tumours whose
pathogenesis and progression are very strongly influenced by genetics. A germline mutation …

[HTML][HTML] SDH mutations establish a hypermethylator phenotype in paraganglioma

E Letouzé, C Martinelli, C Loriot, N Burnichon… - Cancer cell, 2013 - cell.com
Paragangliomas are neuroendocrine tumors frequently associated with mutations in RET,
NF1, VHL, and succinate dehydrogenase (SDHx) genes. Methylome analysis of a large …

Human mitochondrial DNA: roles of inherited and somatic mutations

EA Schon, S DiMauro, M Hirano - Nature Reviews Genetics, 2012 - nature.com
Mutations in the human mitochondrial genome are known to cause an array of diverse
disorders, most of which are maternally inherited, and all of which are associated with …

An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma

A Buffet, N Burnichon, J Favier… - Best practice & research …, 2020 - Elsevier
Paragangliomas and pheochromocytomas (PPGL) are rare neuroendocrine tumours
characterized by a strong genetic determinism. Over the past 20 years, evolution of PPGL …

Succinate dehydrogenase (SDH)‐deficient neoplasia

AJ Gill - Histopathology, 2018 - Wiley Online Library
The succinate dehydrogenase (SDH) complex is a key respiratory enzyme composed of four
subunits: SDHA, SDHB, SDHC and SDHD. Remarkably, immunohistochemistry for SDHB …